News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Rosol Michael Stanley
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 09/13/2022 |
4
| Rosol Michael Stanley (Chief Medical Officer) has filed a Form 4 on NAVIDEA BIOPHARMACEUTICALS, INC.|
Txns:
| Granted 28,150 shares
@ $0
Granted 13,000 shares
@ $0 |
|
| 03/08/2022 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 01/18/2022 |
4
| Rosol Michael Stanley (Chief Medical Officer) has filed a Form 4 on NAVIDEA BIOPHARMACEUTICALS, INC.|
Txns:
| Granted 7,728 shares
@ $0 |
|
| 12/29/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/04/2020 |
4
| Rosol Michael Stanley (Chief Medical Officer) has filed a Form 4 on NAVIDEA BIOPHARMACEUTICALS, INC.|
Txns:
| Granted 6,847 shares
@ $2.62, valued at
$17.9k
|
|
| 02/07/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/03/2019 |
4
| Rosol Michael Stanley (Chief Medical Officer) has filed a Form 4 on NAVIDEA BIOPHARMACEUTICALS, INC.|
Txns:
| Granted 125,000 options
@ $0.38, valued at
$47.5k
|
|
| 12/19/2018 |
3
| Rosol Michael Stanley (Chief Medical Officer) has filed a Form 3 on NAVIDEA BIOPHARMACEUTICALS, INC. |
|
|